Print

Ironwood Pharmaceuticals Provides Second Quarter 2013 Investor Update  
7/23/2013 7:01:07 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today provided an update on its second quarter 2013 and recent business activities.

“The past six months have been a transformative period at Ironwood, thanks to the dedication and hard work of our team,” said Peter Hecht, chief executive officer of Ironwood. “The LINZESS launch is strong and tracking well across all leading indicators, and we and Forest are working closely together to drive all aspects of the launch.

Help employers find you! Check out all the jobs and post your resume.

//-->